Schedule 13D ownership disclosure

PharmaCyte Biotech, Inc.

Security class unavailable · CUSIP: 17512X203

Event date: 2021-10-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-21-001835
Form type
SC 13D
Filer
Iroquois Capital Management, LLC
CIK
CIK 1481867
Filed
Nov 04, 2021
Reporting period
Oct 27, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub